|
|
||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||






* Centre for Research in Infectious Diseases and
National Virus Reference Laboratory, University College Dublin, Dublin, Ireland;
Viral Pathogenesis Research Laboratory and
Laboratory for Research in Neuroinfections, Evandro Chagas Institute for Clinical Research, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil;
¶ Cellular Immunology Laboratory, Department of Biology, National University of Ireland, Maynooth, Ireland; and
|| Department of Immunology, Trinity College Dublin, St. Jamess Hospital, Dublin, Ireland
Human T lymphotropic virus type 2 (HTLV-2) is characterized by a clinically asymptomatic persistent infection in the vast majority of infected individuals. In this study, we have characterized for the first time ex vivo specific CTL responses against the HTLV-2 Tax protein. We could detect CTL responses only against a single HLA-A*0201-restricted Tax2 epitope, comprising residues 11–19 (LLYGYPVYV), among three alleles screened. Virus-specific CTLs could be detected in most evaluated subjects, with frequencies as high as 24% of circulating CD8+ T cells. The frequency of specific CTLs had a statistically significant positive correlation with proviral load levels. The majority of virus-specific CD8+ T cells exhibited an effector memory/terminally differentiated phenotype, expressed high levels of cytotoxicity mediators, including perforin and granzyme B, and lysed in vitro target cells pulsed with Tax2(11–19) synthetic peptide in a dose-dependent manner. Our findings suggest that a strong, effective CTL response may control HTLV-2 viral burden and that this may be a significant factor in maintaining persistent infection and in the prevention of disease in infected individuals.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Address correspondence and reprint requests to Prof. W. Hall, The Centre for Research in Infectious Diseases, University College Dublin, Belfield, Dublin 4, Ireland. E-mail address: william.hall{at}ucd.ie
2 Abbreviations used in this paper: HTLV, human T lymphotropic virus; ATLL, adult T cell leukemia/lymphoma; HAM/TSP, HTLV-1-associated myelopathy/tropical spastic paraparesis; PD-1, programmed death 1; PVL, proviral load; TCM, central memory T cell; TEM, effector memory T cell; TEMRA, terminally differentiated memory T cell; TN, naive T cell.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |